Current perspectives on camptothecins in cancer treatment.

Por Dancey, J., Eisenhauer, E. A.
Publicado em 1996

Early integration of palliative care into standard oncology care: evidence and overcoming barriers to implementation

Por Kain, D.A., Eisenhauer, E.A.
Publicado no Curr Oncol (2016)

The "sagging rope sign" in avascular necrosis in children's hip diseases--confirmation by 3D CT studies.

Por Kim, H. T., Eisenhauer, E., Wenger, D. R.
Publicado em 1995

Prospective evaluation of central venous pressure (CVP) catheters in a large city-county hospital.

Por Eisenhauer, E D, Derveloy, R J, Hastings, P R
Publicado em 1982

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects

Por Hospers, G A P, Eisenhauer, E A, Vries, E G E de
Publicado em 1999

Phase II testing of sunitinib: the National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182–185

Por Buckstein, R., Meyer, R.M., Seymour, L., Biagi, J., MacKay, H., Laurie, S., Eisenhauer, E.
Publicado em 2007

Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group.

Por Eisenhauer, E. A., Silver, H. K., Venner, P. M., Thirlwell, M. P., Weinerman, B., Coppin, C. M.
Publicado em 1987

VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.

Por Evans, W. K., Eisenhauer, E., Hughes, P., Maroun, J. A., Ayoub, J., Shepherd, F. A., Feld, R.
Publicado em 1988

Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21

Por Mackay, H.J., Provencheur, D., Heywood, M., Tu, D., Eisenhauer, E.A., Oza, A.M., Meyer, R.
Publicado em 2011

Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.

Por Skillings, J R, Levine, M, Rayner, H L, Eisenhauer, E, Erlichman, C, Germond, C, Kerr, I, Lofters, W, Maroun, J, Yoshida, S
Publicado em 1991

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours

Por Razak, A R A, Hotte, S J, Siu, L L, Chen, E X, Hirte, H W, Powers, J, Walsh, W, Stayner, L-A, Laughlin, A, Novotny-Diermayr, V, Zhu, J, Eisenhauer, E A
Publicado em 2011

Multigene expression profile testing in breast cancer: is there a role for family physicians?

Por O’Brien, M.A., Carroll, J.C., Manca, D.P., Miedema, B., Groome, P.A., Makuwaza, T., Easley, J., Sopcak, N., Jiang, L., Decker, K., McBride, M.L., Moineddin, R., Permaul, J.A., Heisey, R., Eisenhauer, E.A., Krzyzanowska, M.K., Pruthi, S., Sawka, C., Schneider, N., Sussman, J., Urquhart, R., Versaevel, C., Grunfeld, E.
Publicado no Curr Oncol (2017)